Clinical trials: Femoro-acetabular Impingement (FAI)
Femoroacetabular Impingement
Femoroacetabular Impingement (FAI): The Effectiveness of Physical Therapy
The treatment of femoroacetabular impingement has evolved over the last several years. As the number of arthroscopic hip operations has risen over the last few years, so has the level controversy in regards to the appropriate…
- Trial name
- NCT03077022
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Femoro-acetabular Impingement
Hip Muscle Strength in FAI Versus Normal Controls
Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls. To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular…
- Trial name
- NCT02697097
- Where
- United Kingdom
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
Femoroacetabular Impingement
Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls
Femoroacetabular impingement (FAI) is an orthopaedic condition that is primarily characterized by the presence of anatomic bony abnormalities in the femoral head and/or the acetabulum resulting in an abnormal contact between the…
- Trial name
- CAM-FAI adult (NCT06272292)
- Testing
- EOS, 3D motion lab analysis
- Where
- Belgium
- Volunteers
- 99 people, healthy volunteers welcome
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
Hip Dysplasia, Femoroacetabular Impingement
Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA
An abnormally formed hip joint (cam deformity) is a major cause of osteoarthritis (OA). Individuals may not experience any symptoms until OA is severe due to extensive cartilage loss and changes in underlying bone.
- Conditions
- Hip Dysplasia, Femoroacetabular Impingement, Osteoarthritis
- Trial name
- NCT04080466
- Testing
- Low-dose CT Scan, Blood/Urine Collection, Patient Reported Questionnaires
- Where
- Canada
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Ottawa Hospital Research Institute
Femoroacetabular Impingement
Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
The purpose is to explore the possible benefit of administration of Fisetin, (a senolytic agent) to improve the benefit of Platelet-Rich Plasma and losartan for treatment of femoroacetabular impingement and labral tear.
- Trial name
- NCT05025956
- Testing
- Fisetin
- Where
- United States
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Steadman Philippon Research Institute